(TROW) T. Rowe Price - Overview
Stock: Mutual Funds, Retirement Plans, Asset Management, Advisory Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.21% |
| Yield on Cost 5y | 4.05% |
| Yield CAGR 5y | -8.73% |
| Payout Consistency | 91.9% |
| Payout Ratio | 54.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.1% |
| Relative Tail Risk | -5.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.13 |
| Alpha | -21.02 |
| Character TTM | |
|---|---|
| Beta | 1.167 |
| Beta Downside | 1.025 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.05% |
| CAGR/Max DD | -0.03 |
Description: TROW T. Rowe Price December 19, 2025
T. Rowe Price Group, Inc. (NASDAQ:TROW) is a publicly traded, globally diversified investment manager that offers equity and fixed-income mutual funds to individuals, retirement plans, financial intermediaries, and institutional clients. The firm employs a bottom-up investment process that blends fundamental and quantitative analysis, leverages both internal and external research, and incorporates ESG considerations across its portfolios. It also participates in late-stage venture capital deals, typically committing $3-5 million per transaction.
As of the most recent quarter, T. Rowe Price reported assets under management (AUM) of roughly $1.5 trillion, with net inflows of $12 billion driven largely by strong demand for actively managed fixed-income products amid a volatile interest-rate environment. The company’s revenue growth is closely tied to fee-based income, which benefits from a secular shift toward higher-margin advisory services, while fee compression from passive alternatives remains a sector-wide headwind. Additionally, the firm’s operating margin has stabilized near 30 % after cost-efficiency initiatives launched in 2022.
For a deeper quantitative assessment, you may want to explore ValueRay’s analyst tools to evaluate TROW’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 2.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.02 > 1.0 |
| NWC/Revenue: 57.43% < 20% (prev 53.41%; Δ 4.02% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.49b > Net Income 2.07b |
| Net Debt (-3.18b) to EBITDA (3.12b): -1.02 < 3 |
| Current Ratio: 11.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (219.7m) vs 12m ago -1.39% < -2% |
| Gross Margin: 64.49% > 18% (prev 0.51%; Δ 6398 % > 0.5%) |
| Asset Turnover: 50.68% > 50% (prev 50.42%; Δ 0.25% > 0%) |
| Interest Coverage Ratio: -6.04 > 6 (EBITDA TTM 3.12b / Interest Expense TTM -402.6m) |
Altman Z'' 9.50
| A: 0.28 (Total Current Assets 4.53b - Total Current Liabilities 396.2m) / Total Assets 14.73b |
| B: 0.73 (Retained Earnings 10.82b / Total Assets 14.73b) |
| C: 0.17 (EBIT TTM 2.43b / Avg Total Assets 14.22b) |
| D: 3.92 (Book Value of Equity 10.81b / Total Liabilities 2.76b) |
| Altman-Z'' Score: 9.50 = AAA |
Beneish M -3.19
| DSRI: 0.97 (Receivables 899.4m/890.0m, Revenue 7.21b/6.91b) |
| GMI: 0.79 (GM 64.49% / 50.63%) |
| AQI: 0.97 (AQ_t 0.60 / AQ_t-1 0.62) |
| SGI: 1.04 (Revenue 7.21b / 6.91b) |
| TATA: 0.04 (NI 2.07b - CFO 1.49b) / TA 14.73b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of TROW shares?
Over the past week, the price has changed by +0.05%, over one month by +1.97%, over three months by +4.74% and over the past year by -3.97%.
Is TROW a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 9
- Sell: 4
- StrongSell: 0
What are the forecasts/targets for the TROW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.8 | 2% |
| Analysts Target Price | 107.8 | 2% |
| ValueRay Target Price | 114.1 | 8% |
TROW Fundamental Data Overview January 26, 2026
P/E Forward = 10.3627
P/S = 3.2211
P/B = 2.1316
P/EG = 4.9362
Revenue TTM = 7.21b USD
EBIT TTM = 2.43b USD
EBITDA TTM = 3.12b USD
Long Term Debt = 455.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 455.1m USD (from shortTermDebt, last quarter)
Debt = 455.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.18b USD (from netDebt column, last quarter)
Enterprise Value = 20.03b USD (23.21b + Debt 455.1m - CCE 3.63b)
Interest Coverage Ratio = -6.04 (Ebit TTM 2.43b / Interest Expense TTM -402.6m)
EV/FCF = 13.16x (Enterprise Value 20.03b / FCF TTM 1.52b)
FCF Yield = 7.60% (FCF TTM 1.52b / Enterprise Value 20.03b)
FCF Margin = 21.12% (FCF TTM 1.52b / Revenue TTM 7.21b)
Net Margin = 28.69% (Net Income TTM 2.07b / Revenue TTM 7.21b)
Gross Margin = 64.49% ((Revenue TTM 7.21b - Cost of Revenue TTM 2.56b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 48.06%)
Tobins Q-Ratio = 1.36 (Enterprise Value 20.03b / Total Assets 14.73b)
Interest Expense / Debt = 249.5% (Interest Expense 1.14b / Debt 455.1m)
Taxrate = 22.13% (195.1m / 881.6m)
NOPAT = 1.89b (EBIT 2.43b * (1 - 22.13%))
Current Ratio = 11.44 (Total Current Assets 4.53b / Total Current Liabilities 396.2m)
Debt / Equity = 0.04 (Debt 455.1m / totalStockholderEquity, last quarter 10.81b)
Debt / EBITDA = -1.02 (Net Debt -3.18b / EBITDA 3.12b)
Debt / FCF = -2.09 (Net Debt -3.18b / FCF TTM 1.52b)
Total Stockholder Equity = 10.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.54% (Net Income 2.07b / Total Assets 14.73b)
RoE = 19.63% (Net Income TTM 2.07b / Total Stockholder Equity 10.53b)
RoCE = 22.15% (EBIT 2.43b / Capital Employed (Equity 10.53b + L.T.Debt 455.1m))
RoIC = 17.99% (NOPAT 1.89b / Invested Capital 10.53b)
WACC = 10.01% (E(23.21b)/V(23.66b) * Re(10.21%) + (debt cost/tax rate unavailable))
Discount Rate = 10.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.96%
[DCF Debug] Terminal Value 67.76% ; FCFF base≈1.48b ; Y1≈1.25b ; Y5≈946.3m
Fair Price DCF = 72.01 (EV 12.54b - Net Debt -3.18b = Equity 15.71b / Shares 218.2m; r=10.01% [WACC]; 5y FCF grow -18.74% → 2.90% )
EPS Correlation: 21.77 | EPS CAGR: -3.16% | SUE: 1.59 | # QB: 1
Revenue Correlation: 29.60 | Revenue CAGR: -0.94% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.50 | Chg30d=-0.011 | Revisions Net=+4 | Analysts=8
EPS next Year (2026-12-31): EPS=10.30 | Chg30d=+0.012 | Revisions Net=+4 | Growth EPS=+6.1% | Growth Revenue=+5.3%